Haemonetics Corp (HAE) stock

HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3

Financials through Q2 FY2027, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3064% above fair value

$122.94+0.23 (+0.19%)

Close on Nov 13, 2026Market cap $5.59BP/E 54.9Yield –

Haemonetics statistics

101 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Feb 4, 2027 (estimated, before the open)
Last ex-dividend date: No dividends
Fundamentals through: Sep 26, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $5.59B; $498.53M
Enterprise Value: $6.46B; $433.11M
PE Ratio: 54.88; 29.52
PS Ratio: 4.05; 2.94
PB Ratio: 6.23; 3.24
P/FCF Ratio: 18.75; 26.31
P/OCF Ratio: 16.22; 21.97

Enterprise valuationIndustry

EV / Sales: 4.67; 2.60
EV / EBITDA: 22.53; 18.41
EV / EBIT: 36.49; 24.14
EV / FCF: 21.65; 27.51

Share statisticsIndustry

Shares Outstanding: 45M; 43M
Shares Change (YoY): -5.39%; 3.32%
Shares Change (QoQ): 0.12%; 0.20%
Float: 45M; 37M
Shares Held by Insiders: 1.82%; 10.5%
Shares Held by Institutions: 109.1%; 60.5%

Short sellingIndustry

Short Interest: 4M; –
Short Interest Change: 4.99%; -2.57%
Short % of Float: 8.06%; 5.11%
Short % of Shares Outstanding: 7.91%; 3.98%
Days to Cover: 6.27; 3.94

Stock price statisticsIndustry

52-Week High: $132.00; –
52-Week Low: $51.00; –
20-Day Moving Average: $120.21; –
50-Day Moving Average: $113.31; –
200-Day Moving Average: $81.26; –
Average True Range (14): $4.42; –
Price Change (1 Week): 2.51%; 0.99%
Price Change (1 Month): 1.36%; -3.52%
Price Change (3 Months): 36.2%; -7.86%
Price Change (6 Months): 118.4%; -1.12%
Price Change (YTD): 53.4%; -2.92%
Price Change (1 Year): 68.1%; -1.37%
Price Change (3 Years): 37.5%; 3.24%
Price Change (5 Years): 105.0%; -50.4%
Price Change (10 Years): 219.2%; 58.9%
Average Volume (10 Days): 785,683; –
Average Volume (20 Days): 685,219; –
Average Volume (90 Days): 714,417; –
Relative Volume: 0.62; 0.76
Relative Strength Index (14): 58.8; 46.7
Volatility (1 Year): 41.0%; 64.2%
Beta (5 Years): 0.64; 1.04

MarginsIndustry

Gross Margin: 59.6%; 55.9%
Operating Margin: 12.8%; -5.12%
Pretax Margin: 10.3%; -2.32%
Profit Margin: 7.52%; -9.29%
EBITDA Margin: 20.7%; -2.52%
FCF Margin: 21.6%; 0.65%

Returns on capitalIndustry

Return on Equity (ROE): 11.9%; -17.3%
Return on Assets (ROA): 4.28%; -12.3%
Return on Invested Capital (ROIC): 7.32%; -2.83%
Return on Capital Employed (ROCE): 8.39%; -8.13%

Financial positionIndustry

Current Ratio: 2.84; 2.49
Quick Ratio: 1.61; 1.53
Debt / Equity: 1.25; 0.42
Debt / EBITDA: 3.92; 2.23
Debt / FCF: 3.77; 3.62
Net Debt / EBITDA: 3.01; 1.49

GrowthIndustry

Revenue Growth (YoY): 4.11%; 9.42%
Net Income Growth (YoY): -38.2%; 13.4%
EPS Growth (YoY): -34.5%; 15.1%
FCF Growth (YoY): 16.5%; 7.64%
Revenue Growth (3Y CAGR): 4.51%; 7.08%
Revenue Growth (5Y CAGR): 8.91%; 11.8%
EPS Growth (3Y CAGR): -2.91%; 3.11%
EPS Growth (5Y CAGR): 5.75%; 7.64%

EfficiencyIndustry

Asset Turnover: 0.57; 0.59
Inventory Turnover: 1.74; 2.20
WACC: 7.80%; 9.91%

Income statement (TTM)Industry

Revenue: $1.38B; $108.17M
Gross Profit: $824.31M; $62.29M
Operating Income: $176.95M; -$3.72M
Pretax Income: $142.01M; -$1.83M
Net Income: $103.91M; -$6.19M
EBITDA: $286.52M; -$1.98M
EPS (Diluted): $2.24; -$0.11

Balance sheetIndustry

Cash & Short-Term Investments: $260.71M; $38.97M
Total Debt: $1.12B; $96.00M
Net Cash (Debt): -$863.05M; $3.95M
Net Cash Per Share: -$18.97; $0.26
Equity (Book Value): $898.50M; $63.80M
Book Value Per Share: $19.75; $3.26
Tangible Book Value: -$184.97M; $11.61M
Working Capital: $554.69M; $57.32M

Cash flow (TTM)Industry

Operating Cash Flow: $344.93M; -$483.87K
Capital Expenditures: -$46.69M; -$3.94M
Free Cash Flow: $298.24M; -$238.00K
FCF Per Share: $6.56; -$0.00

Dividends and yieldsIndustry

Earnings Yield: 1.86%; -4.76%
FCF Yield: 5.33%; 0.28%

Taxes and interestIndustry

Income Tax: $38.10M; $1.55M
Effective Tax Rate: 26.8%; 18.0%

Scores and fair valueIndustry

Graham Number: $31.55; $38.11
Graham Upside: -74.3%; -56.1%
Altman Z-Score: 3.52; 2.47
Piotroski F-Score: 6; 5
Beneish M-Score: -2.82; -2.64
Lynch Fair Value: $12.88; –
Lynch Upside: -89.5%; -45.2%

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	HAE	S&P 500	Difference	HAE per year	S&P 500 per year
1 month	+1.0%	-3.0%	+4.0 pts
3 months	+36.0%	-2.8%	+38.8 pts
Year to date	+53.4%	+11.5%	+41.9 pts
1 year	+66.3%	+13.5%	+52.9 pts
3 years	+41.8%	+77.7%	−35.9 pts	+12.4%	+21.1%
5 years	+105.0%	+72.6%	+32.4 pts	+15.4%	+11.5%
10 years	+215.6%	+308.2%	−92.6 pts	+12.2%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

4M HAE shares were sold short on Oct 30, 2026, up 5.0% from the previous report, or 8.06% of the shares available to trade. At recent volumes it would take 6.3 days to buy them back. Over the last 20 sessions, 54.0% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	3,599,250	+5.0%	574,460	6.3
Oct 15, 2026	3,428,091	+12.8%	881,291	3.9
Sep 30, 2026	3,037,763	-11.3%	569,315	5.3
Sep 15, 2026	3,424,696	+19.6%	602,088	5.7
Aug 31, 2026	2,863,501	+3.7%	841,772	3.4
Aug 14, 2026	2,761,115	-5.5%	888,797	3.1
Jul 31, 2026	2,921,809	+8.2%	638,654	4.6
Jul 15, 2026	2,701,605	-7.3%	640,781	4.2
Jun 30, 2026	2,914,882	-3.3%	931,315	3.1
Jun 15, 2026	3,013,604	+1.9%	1,117,697	2.7
May 29, 2026	2,956,590	+14.5%	953,923	3.1
May 15, 2026	2,583,187	+30.5%	1,061,034	2.4